AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 24 November 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Beceiro, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beceiro, A.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00485-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Genetic variability among ampC genes from Acinetobacter genomic species 3

Alejandro Beceiro, Astrid Pérez, Felipe Fernández-Cuenca, Luis Martínez-Martínez, Alvaro Pascual, Jordi Vila, Jesús Rodríguez-Baño, Jose Miguel Cisneros, Jerónimo Pachón, Germán Bou*, and the Spanish Group for Nosocomial Infection (GEIH)

Servicio de Microbiología-Unidad de Investigación, Complejo Hospitalario Universitario Juan Canalejo, 15006 La Coruña; Servicios de Microbiología y de Enfermedades Infecciosas, Hospital Virgen Macarena, 41071 Sevilla; Servicio de Microbiología. Hospital Universitario Marqués de Valdecilla, Santander; Servei de Microbiología, Hospital Clinic, 08036 Barcelona; and Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain

* To whom correspondence should be addressed. Email: germanbou{at}canalejo.org.


   Abstract

As a part of a nationwide study in Spain, 15 clinical isolates of Acinetobacter genomic species 3 (AG3) were analysed. The main objective of the study was to characterize the ampC genes from these isolates and to determine their involvement in {beta}-lactam resistance in Acinetobacter G3. The 15 AG3 isolates showed different profiles of resistance to ampicillin (range of MICs 12 to >256 µg/mL). Nucleotide sequencing of the 15 ampC genes yielded 13 new AmpC enzymes (ADC-12 to ADC-24). The 13 AG3 enzymes showed 93.7-96.1% amino-acid identity with respect to the AmpC enzyme from A. baumannii (ADC-1 enzyme). Eight out of 15 ampC genes were expressed in E. coli under the control of a common promoter and with the exception of one isolate (#65, which showed lower {beta}-lactam MIC values), significant differences were not revealed in overall {beta}-lactam MICs for E. coli expressing AG3 ampC genes. No significant differences in ampC gene expression in AG3 clinical isolates were revealed by RT-PCR and analysis. A detailed analysis of the 13 AmpC protein sequences revealed that amino acid replacements (in comparison with those of ADC-1) mainly occurred in the same positions, although none were located in important functional domains such as the omega loop or conserved {beta}-lactamase motifs. Kinetic experiments performed with three representative AmpC enzymes (ADC-14, -16 and -18) in some cases revealed dramatic changes in Km and kcat values for {beta}-lactams. No ISAba1 was detected upstream of the ampC genes. Our results reveal 13 new ampC genes in AG3. The enzymes showed a moderate degree of variability and they are tentatively named as ADC-12 to ADC-24







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.